Role of high density lipoproteins in the regression of atherosclerosis
- PMID: 1424054
Role of high density lipoproteins in the regression of atherosclerosis
Abstract
Atherosclerosis is a slowly progressive disease characterized by the accumulation of cholesterol within the vessel wall. Plasma lipoproteins are particles of complex lipid and protein composition that transport lipids in blood. Low density lipoproteins (LDL) and high density lipoproteins (HDL) are the major cholesterol-carrier lipoproteins. LDL seem to be responsible for the delivery of lipids (cholesterol) from the liver to the tissues. Compelling evidence supports the concept that the lipids deposited in the arteriosclerotic lesions are derived primarily from plasma LDL. The term "reverse cholesterol transport" describes the transport of cholesterol from extrahepatic tissues to the liver, where it may be metabolized. Reverse cholesterol transport seems to be the major route for removal of the exchangeable cholesterol deposited in the extrahepatic tissue. It has been postulated that a major role of the plasma HDL particle is to act as a scavenger of tissue cholesterol. The hypothesis that high levels of plasma HDL are protective against coronary artery disease (CAD) was initially proposed by Barr et al in the early 1950s, but it was overlooked until confirmed by the Tromso and Framingham studies in 1977, which showed an inverse relation between HDL plasma levels and incidence of CAD. Similar observations have been made in 15 major experimental studies including eight countries.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[The effect of cholesterol oxidation products on the disruption of lipid metabolism and atherosclerotic damage of the aorta in rabbits].Arkh Patol. 1988;50(11):15-22. Arkh Patol. 1988. PMID: 3233067 Russian.
-
[Lipids and blood vessels].Schweiz Rundsch Med Prax. 1993 Nov 23;82(47):1344-7. Schweiz Rundsch Med Prax. 1993. PMID: 8272699 German.
-
The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.Mol Nutr Food Res. 2005 Nov;49(11):1075-82. doi: 10.1002/mnfr.200500063. Mol Nutr Food Res. 2005. PMID: 16270280 Review.
-
Plasma high density lipoproteins and coronary artery disease.Adv Myocardiol. 1980;2:513-25. Adv Myocardiol. 1980. PMID: 7423063
-
HDL metabolism and atherosclerosis.J Cardiovasc Pharmacol. 1990;16 Suppl 9:S15-20. J Cardiovasc Pharmacol. 1990. PMID: 1710740 Review.
Cited by
-
Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods.Lipids. 2003 Mar;38(3):209-18. doi: 10.1007/s11745-003-1053-5. Lipids. 2003. PMID: 12784860
-
Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein.Int J Mol Sci. 2021 Dec 20;22(24):13624. doi: 10.3390/ijms222413624. Int J Mol Sci. 2021. PMID: 34948420 Free PMC article.
-
Endurance training enhances ABCA1 expression in rat small intestine.Eur J Appl Physiol. 2009 Oct;107(3):351-8. doi: 10.1007/s00421-009-1133-3. Epub 2009 Jul 24. Eur J Appl Physiol. 2009. PMID: 19629515
-
Current, new and future treatments in dyslipidaemia and atherosclerosis.Drugs. 2000 Jul;60(1):55-93. doi: 10.2165/00003495-200060010-00005. Drugs. 2000. PMID: 10929930 Review.
-
Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins.Heart Vessels. 2005 Sep;20(5):217-23. doi: 10.1007/s00380-005-0836-6. Heart Vessels. 2005. PMID: 16160904 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous